Department of Medicinal Chemistry, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, CA 94080, USA.
Bioorg Med Chem Lett. 2009 Nov 15;19(22):6386-91. doi: 10.1016/j.bmcl.2009.09.061. Epub 2009 Sep 19.
Using structure-guided design, hydroxyethylamine BACE-1 inhibitors were optimized to nanomolar Abeta cellular inhibition with selectivity against cathepsin-D. X-ray crystallography illuminated the S1' residues critical to this effort, which culminated in compounds 56 and 57 that exhibited potency and selectivity but poor permeability and high P-gp efflux.
利用结构导向设计,羟乙胺 BACE-1 抑制剂被优化为纳摩尔级的 Abeta 细胞抑制作用,对组织蛋白酶-D 具有选择性。X 射线晶体学揭示了对这项工作至关重要的 S1' 残基,最终得到了化合物 56 和 57,它们表现出了活性和选择性,但通透性差,P-糖蛋白外排率高。